Compare TEVA & NTNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | NTNX |
|---|---|---|
| Founded | 1901 | 2009 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.2B | 20.5B |
| IPO Year | N/A | 2016 |
| Metric | TEVA | NTNX |
|---|---|---|
| Price | $28.38 | $47.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 16 |
| Target Price | $27.00 | ★ $76.20 |
| AVG Volume (30 Days) | ★ 11.4M | 4.9M |
| Earning Date | 11-05-2025 | 11-25-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | 0.62 | ★ 0.76 |
| Revenue | ★ $16,776,000,000.00 | $2,617,547,000.00 |
| Revenue This Year | $4.74 | $15.92 |
| Revenue Next Year | $0.48 | $13.80 |
| P/E Ratio | ★ $46.12 | $62.39 |
| Revenue Growth | 0.02 | ★ 17.45 |
| 52 Week Low | $12.47 | $46.12 |
| 52 Week High | $28.68 | $83.36 |
| Indicator | TEVA | NTNX |
|---|---|---|
| Relative Strength Index (RSI) | 80.93 | 19.87 |
| Support Level | $24.01 | $46.12 |
| Resistance Level | $26.96 | $48.19 |
| Average True Range (ATR) | 0.68 | 1.92 |
| MACD | 0.19 | -1.08 |
| Stochastic Oscillator | 94.65 | 6.19 |
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Nutanix Inc is engaged in cloud software, offering organizations a single platform for running applications and managing data, anywhere. Its Nutanix Cloud Platform is designed to enable organizations to build a hybrid multicloud infrastructure, providing a consistent cloud operating model with a single platform for running applications and managing data in core data centers, at the edge, and in public clouds, all while supporting a variety of hypervisors and container platforms. The company is into a single operating and reportable segment that is subscription-based business model. Key revenue is generated from United States.